Myelofibrose: Ein Tyrosinkinase-Inhibitor erweitert die therapeutischen Möglichkeiten

Authors

Institutions

Publication Details

Journal
Kompass Onkologie
Published
2024-08-20
DOI
https://doi.org/10.1159/000540902
Primary Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Myelofibrose: Ein Tyrosinkinase-Inhibitor erweitert die therapeutischen Möglichkeiten

Sonja Heibl
Kompass Onkologie
Myeloproliferative Neoplasms: Diagnosis and Treatment
article

Myelofibrose: Ein Tyrosinkinase-Inhibitor erweitert die therapeutischen Möglichkeiten

Sonja Heibl
article en

Abstract

No abstract available for this paper.
Kompass OnkologieVol. 11(3)
Klinikum Wels-Grieskirchen (AT)
Openalex Percentile: Top 75%
Myeloproliferative Neoplasms: Diagnosis and Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Myelofibrose: Ein Tyrosinkinase-Inhibitor erweitert die therapeutischen Möglichkeiten — Sonja Heibl · Kompass Onkologie (2024) | TGRS Research Map | TGRS